Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta

American Journal of Obstetrics and Gynecology

Volumn 216, Issue 3, 2017, Pages 287.e1-287.e16

  Labarrere, Carlos A ^a,b   DiCarlo, Hector L ^c   Bammerlin, Elaine ^d   Hardin, James W ^f   Kim, Yeon M ^g   Chaemsaithong, Piya ⁱ   Haas, David M ^e   Kassab, Ghassan S ^b   Romero, Roberto ^h,i,j,k  

^a CBL Partners for Life   (United States)

^b CALIFORNIA MEDICAL INNOVATIONS INSTITUTE   (United States)

^c Westside Regional Medical Center   (United States)

^d INDIANA UNIVERSITY HEALTH   (United States)

^e Indiana University   (United States)

^f UNIVERSITY OF SOUTH CAROLINA   (United States)

^g Inje University College of Medicine   (South Korea)

^h WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k MICHIGAN STATE UNIVERSITY   (United States)

more..

Author keywords

acute atherosis; endothelial activation; failure of physiologic transformation; ICAM 1; placental basal plate; spiral arteries; trophoblast activation

Indexed keywords

ALPHA ACTIN; CYTOKERATIN; INTERCELLULAR ADHESION MOLECULE 1;

ACUTE ATHEROSIS; ARTERY DISEASE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL FUNCTION; CELL ACTIVATION; CELL ADHESION; CROSS-SECTIONAL STUDY; ENDOTHELIUM CELL; FEMALE; FETUS DEATH; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PLACENTA; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL FOR DATE INFANT; SPIRAL ARTERY; TROPHOBLAST; UTERINE ARTERY; ACUTE DISEASE; ARTERY; CYTOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ACUTE DISEASE; ARTERIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TROPHOBLASTS; VASCULAR DISEASES;

EID: 85019920778     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.12.029     Document Type: Article

References (176)

1. 1 Brosens, I., Robertson, W.B., Dixon, H.G., The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 93 (1967), 569–579.
2. 2 De Wolf, F., Robertson, W.B., Brosens, I., The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 123 (1975), 164–174.
3. 3 Brosens, I., Khong, T.Y., Defective spiral artery remodeling. Pijnenborg, R., Brosens, I., Romero, R., (eds.) Placental bed disorders, 1st ed., 2010, Cambridge University Press, New York, NY, 11–21.
4. 4 Whitley, G.S., Cartwright, J.E., Cellular and molecular regulation of spiral artery remodeling: lessons from the cardiovascular field. Placenta 31 (2010), 465–474.
5. 5 Osol, G., Mandala, M., Maternal uterine vascular remodeling during pregnancy. Physiology (Bethesda) 24 (2009), 58–71.
6. 6 Osol, G., Moore, L.G., Maternal uterine vascular remodeling during pregnancy. Microcirculation 21 (2014), 38–47.
7. 7 Burton, G.J., Woods, A.W., Jauniaux, E., Kingdom, J.C.P., Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30 (2009), 473–482.
8. 8 Robertson, W.B., Brosens, I., Dixon, G., Uteroplacental vascular pathology. Eur J Obstet Gynecol Reprod Biol 5 (1975), 47–65.
9. 9 Pijnenborg, R., Bland, J.M., Robertson, W.B., et al. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4 (1983), 397–413.
10. 10 Craven, C.M., Morgan, T., Ward, K., Decidual spiral artery remodeling begins before cellular interaction with cytotrophoblasts. Placenta 19 (1998), 241–252.
11. 11 Staff, A.C., Dechend, R., Pijnenborg, R., Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 56 (2010), 1026–1034.
12. 12 Smith, S.D., Dunk, C.E., Aplin, J.D., et al. Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 174 (2009), 1959–1971.
13. 13 Harris, L.K., Review: trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel. Placenta 31:Suppl (2010), S93–S98.
14. 14 Hazan, A.D., Smith, S.D., Jones, R.L., et al. Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro. Am J Pathol 177 (2010), 1017–1030.
15. 15 Lash, G.E., Otun, H.A., Innes, B.A., et al. Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age. Hum Reprod 25 (2010), 1137–1145.
16. 16 Harris, L.K., IFPA Gabor Than Award Lecture: Transformation of the spiral arteries in human pregnancy: key events in the remodeling timeline. Placenta 32:Suppl (2011), S154–S158.
17. 17 Robson, A., Harris, L.K., Innes, B.A., et al. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J 26 (2012), 4876–4885.
18. 18 Tessier, D.R., Yockell-Lelievre, J., Gruslin, A., Uterine spiral artery remodeling: the role of uterine natural killer cells and extravillous trophoblasts in normal and high-risk human pregnancies. Am J Reprod Immunol 74 (2015), 1–11.
19. 19 Pijnenborg, R., Vercruysse, L., Hanssens, M., The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27 (2006), 939–958.
20. 20 Espinoza, J., Romero, R., Mee Kim, Y., et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 34 (2006), 447–458.
21. 21 Brosens, I., Pijnenborg, R., Vercruysse, L., et al. The “great obstetrical syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 204 (2011), 193–201.
22. 22 Brosens, I., The placental bed [thesis]. 1965, University of London, London.
23. 23 Brosens, I., Dixon, H.G., The anatomy of the maternal side of the placenta. J Obstet Gynaecol Br Commonw 73 (1966), 357–363.
24. 24 Brosens, I., Derwig, I., Brosens, J., et al. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders?. Hum Reprod 25 (2010), 569–574.
25. 25 Khong, Y., Brosens, I., Defective deep placentation. Best Pract Res Clin Obstet Gynaecol 25 (2011), 301–311.
26. 26 Pijnenborg, R., Vercruysse, L., Brosens, I., Deep placentation. Best Pract Res Clin Obstet Gynaecol 25 (2011), 273–285.
27. 27 Brosens, I., Benagiano, G., Brosens, J.J., The potential perinatal origin of placentation disorders in the young primigravida. Am J Obstet Gynecol 212 (2015), 580–585.
28. 28 Khong, T.Y., Liddell, H.S., Robertson, W.B., Defective hemochorial placentation as a cause of miscarriage: a preliminary study. Br J Obstet Gynaecol 94 (1987), 649–655.
29. 29 Michel, M.Z., Khong, T.Y., Clark, D.A., et al. A morphological and immunological study of human placental bed biopsies in miscarriage. Br J Obstet Gynaecol 97 (1990), 984–988.
30. 30 Ball, E., Bulmer, J.N., Ayis, S., et al. Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol 208 (2006), 535–542.
31. 31 Dommisse, J., Tiltman, A.J., Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 99 (1992), 651–654.
32. 32 Brosens, I.A., Robertson, W.B., Dixon, H.G., The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1 (1972), 177–191.
33. 33 Labarrere, C., Althabe, O., Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 20 (1985), 1–11.
34. 34 Khong, T.Y., De Wolf, F., Robertson, W.B., et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93 (1986), 1049–1059.
35. 35 Althabe, O., Labarrere, C., Telenta, M., Maternal vascular lesions in placentae of small-for-gestational-age infants. Placenta 6 (1985), 265–276.
36. 36 Kim, Y.M., Bujold, E., Chaiworapongsa, T., et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 189 (2003), 1063–1069.
37. 37 Arias, F., Rodriquez, L., Rayne, S.C., et al. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 168 (1993), 585–591.
38. 38 Kim, Y.M., Chaiworapongsa, T., Gomez, R., et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 187 (2002), 1137–1142.
39. 39 Labarrere, C.A., Catoggio, L.J., Mullen, E.G., et al. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol 12 (1986), 78–86.
40. 40 Lyall, F., Robson, S.C., Bulmer, J.N., Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction. Relationship to clinical outcome. Hypertension 62 (2013), 1046–1054.
41. 41 Labarrere, C., Althabe, O., Chronic villitis of unknown etiology and decidual maternal vasculopathies in sustained chronic hypertension. Eur J Obstet Gynecol Reprod Biol 21 (1986), 27–32.
42. 42 Labarrere, C.A., Althabe, O.H., Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and small-for-gestational-age infants. Br J Obstet Gynaecol 94 (1987), 1113–1118.
43. 43 Labarrere, C.A., Acute atherosis. A histopathological hallmark of immune aggression?. Placenta 9 (1988), 95–108.
44. 44 Labarrere, C.A., Faulk, W.P., Antigenic identification of cells in spiral artery trophoblastic invasion: validation of histologic studies by triple-antibody immunocytochemistry. Am J Obstet Gynecol 171 (1994), 165–171.
45. 45 Avagliano, L., Bulfamante, G.P., Morabito, A., Marconi, A.M., Abnormal spiral artery remodeling in the decidual segment during pregnancy: from histology to clinical correlation. J Clin Pathol 64 (2011), 1064–1068.
46. 46 Libby, P., Ridker, P.M., Maseri, A., Inflammation and atherosclerosis. Circulation 105 (2002), 1135–1143.
47. 47 Libby, P., Inflammation in atherosclerosis. Nature 420 (2002), 868–874.
48. 48 Young, J.L., Libby, P., Schonbeck, U., Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88 (2002), 554–567.
49. 49 Hansson, G.K., Libby, P., The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 (2006), 508–519.
50. 50 Libby, P., Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65 (2007), S140–S146.
51. 51 Rocha, V.Z., Libby, P., Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6 (2009), 399–409.
52. 52 Galkina, E., Ley, K., Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 27 (2009), 165–197.
53. 53 Libby, P., Okamoto, Y., Rocha, V.Z., et al. Inflammation in atherosclerosis: transition from theory to practice. Circ J 74 (2010), 213–220.
54. 54 Brosens, I., Renaer, M., On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaecol Br Commonw 79 (1972), 794–799.
55. 55 Brosens, I.A., Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol 4 (1977), 573–593.
56. 56 Kaufmann, P., Black, S., Huppertz, B., Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69 (2003), 1–7.
57. 57 Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 10 (2014), 466–480.
58. 58 Cotechini, T., Komisarenko, M., Sperou, A., et al. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med 211 (2014), 165–179.
59. 59 Sacks, G.P., Studena, K., Sargent, K., et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179 (1998), 80–86.
60. 60 Redman, C.W., Sacks, G.P., Sargent, I.L., Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180 (1999), 499–506.
61. 61 Gervasi, M.T., Chaiworapongsa, T., Pacora, P., et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 185 (2001), 792–797.
62. 62 Lau, S.Y., Guild, S.J., Barrett, C.J., et al. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol 70 (2013), 412–427.
63. 63 Boyd, E.M., The lipemia of pregnancy. J Clin Invest 13 (1934), 347–363.
64. 64 Potter, J.M., Nestel, P.J., The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 133 (1979), 165–170.
65. 65 Hubel, C.A., McLaughlin, M.K., Evans, R.W., et al. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 174 (1996), 975–982.
66. 66 Baker, A.M., Klein, R.L., Moss, K.L., et al. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol 201 (2009), 293.e1–293.e4.
67. 67 Belo, L., Santos-Silva, A., Quintanilha, A., et al. Similarities between pre-eclampsia and atherosclerosis: a protective effect of physical exercise?. Curr Med Chem 15 (2008), 2223–2229.
68. 68 Roberts, J.M., Redman, C.W., Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341 (1993), 1447–1451.
69. 69 Lain, K.Y., Roberts, J.M., Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287 (2002), 3183–3186.
70. 70 Coelho, T.M., Sass, N., Camano, L., et al. Microvessel density in the placental bed among preeclampsia patients. Sao Paulo Med J 124 (2006), 96–100.
71. 71 Labarrere, C.A., Nelson, D.R., Faulk, W.P., Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA 278 (1997), 1169–1175.
72. 72 Labarrere, C.A., Nelson, D.R., Miller, S.J., et al. Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure. Circulation 102 (2000), 1549–1555.
73. 73 Labarrere, C.A., Lee, J.B., Nelson, D.R., et al. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet 360 (2002), 1462–1467.
74. 74 Labarrere, C.A., Jaeger, B.R., Biomarkers of heart transplant rejection: the good, the bad, and the ugly!. Transl Res 159 (2012), 238–251.
75. 75 Labarrere, C.A., Woods, J.R., Hardin, J.W., et al. Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients. PLoS One, 7, 2012, e36100.
76. 76 Labarrere, C.A., Woods, J.R., Hardin, J.W., et al. Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients. PLoS One, 9, 2014, e113260.
77. 77 Schnoor, M., Alcaide, P., Voisin, M.-B., van Buul, J.D., Crossing the vascular wall: common and unique mechanisms exploited by different leukocyte subsets during extravasation. Mediators Inflamm, 2015, 2015, 946509.
78. 78 Gerhardt, T., Ley, K., Monocyte trafficking across the vessel wall. Cardiovasc Res 107 (2015), 321–330.
79. 79 Labarrere, C.A., Zaloga, G.P., C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 117 (2004), 499–507.
80. 80 Roberts, J.M., Taylor, R.N., Musci, T.J., et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989), 1200–1204.
81. 81 Roberts, J.M., Edep, M.E., Goldfien, A., et al. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol 27 (1992), 101–108.
82. 82 Wang, Y., Zhang, Y., Lewis, D.F., et al. Protease chymotrypsin mediates the endothelial expression of P- and E-selectin, but not ICAM and VCAM, induced by placental trophoblasts from pre-eclamptic pregnancies. Placenta 24 (2003), 851–861.
83. 83 Wang, X., Athayde, N., Trudinger, B., Microvascular endothelial cell activation is present in the umbilical placental microcirculation in fetal placental vascular disease. Am J Obstet Gynecol 190 (2004), 596–601.
84. 84 Chen, Q., Guo, F., Hensby-Bennett, S., et al. Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: implications for the pathogenesis of preeclampsia. Placenta 33 (2012), 810–815.
85. 85 Chen, Q., Guo, F., Liu, S., et al. Calcium channel blockers prevent endothelial cell activation in response to necrotic trophoblast debris: possible relevance to pre-eclampsia. Cardiovasc Res 96 (2012), 484–493.
86. 86 Shen, F., Wei, J., Snowise, S., et al. Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium. Placenta 35 (2014), 839–847.
87. 87 Chen, Q., Stone, P.R., McCowan, L.M., et al. Activated endothelial cells resist displacement by trophoblast in vitro. Placenta 28 (2007), 743–747.
88. 88 Oken, E., Kleinman, K.P., Rich-Edwards, J., Gillman, M.W., A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr, 3, 2003, 6.
89. 89 Juge-Aubry, C.E., Henrichot, E., Meier, C.A., Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 19 (2005), 547–566.
90. 90 Benirschke, K., Burton, G.J., Baergen, R.N., Pathology of the human placenta. 2012, Springer-Verlag, Heidelberg (Germany).
91. 91 Labarrere, C.A., Faulk, W.P., Intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigens are expressed on endovascular cytotrophoblasts in abnormal pregnancies. Am J Reprod Immunol 33 (1995), 47–53.
92. 92 Reister, F., Frank, H.G., Heyl, W., et al. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 20 (1999), 229–233.
93. 93 DiFederico, E., Genbacev, O., Fisher, S.J., Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155 (1999), 293–301.
94. 94 Pijnenborg, R., McLaughlin, P.J., Vercruysse, L., et al. Immunolocalization of tumor necrosis factor-alpha (TNF-alpha) in the placental bed of normotensive and hypertensive human pregnancies. Placenta 19 (1998), 231–239.
95. 95 Harsem, N.K., Roald, B., Braekke, K., et al. Acute atherosis in decidual tissue: not associated with systemic oxidative stress in preeclampsia. Placenta 28 (2007), 958–964.
96. 96 Staff, A.C., Dechend, R., Redman, C.W., Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta 34:Suppl (2013), S73–S78.
97. 97 Staff, A.C., Johnsen, G.M., Dechend, R., et al. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol 101-102 (2014), 120–126.
98. 98 Hiby, S.E., Walker, J.J., O'Shaughnessy, K.M., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 (2004), 957–965.
99. 99 Moffett, A., Loke, C., Immunology of placentation in eutherian mammals. Nat Rev Immunol 6 (2006), 584–594.
100. 100 Moffett, A., Hiby, S.E., How does the maternal immune system contribute to the development of pre-eclampsia?. Placenta 28:Suppl (2007), S51–S56.
101. 101 Redman, C.W., Sargent, I.L., Immunology of pre-eclampsia. Am J Reprod Immunol 63 (2010), 534–543.
102. 102 Tilburgs, T., Scherjon, S.A., van der Mast, B.J., et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 82 (2009), 148–157.
103. 103 Young, J., The etiology of eclampsia and albuminuria and their relation to accidental hemorrhage: (an anatomical and experimental investigation). Proc R Soc Med 7 (1914), 307–348.
104. 104 Bujold, E., Romero, R., Chaiworapongsa, T., et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med 18 (2005), 9–16.
105. 105 Gilbert, J.S., Babcock, S.A., Granger, J.P., Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50 (2007), 1142–1147.
106. 106 Makris, A., Thornton, C., Thompson, J., et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 71 (2007), 977–984.
107. 107 Kusanovic, J.P., Romero, R., Chaiworapongsa, T., et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 22 (2009), 1021–1038.
108. 108 Verlohren, S., Galindo, A., Schlembach, D., et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 202 (2010), 161.e1–161.e11.
109. 109 Vaisbuch, E., Whitty, J.E., Hassan, S.S., et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol 204 (2011), 152.e1–152.e9.
110. 110 Soto, E., Romero, R., Kusanovic, J.P., et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med 25 (2012), 498–507.
111. 111 McElrath, T.F., Lim, K.H., Pare, E., et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol 207 (2012), 407.e1–407.e7.
112. 112 Wei, S.Q., Audibert, F., Luo, Z.C., et al. Maternal plasma 25-hydroxyvitamin D levels, angiogenic factors, and preeclampsia. Am J Obstet Gynecol 208 (2013), 390.e1–390.e6.
113. 113 Maynard, S.E., Crawford, S.L., Bathgate, S., et al. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Am J Obstet Gynecol 209 (2013), 53.e1–53.e9.
114. 114 Maynard, S.E., Min, J.Y., Merchan, J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003), 649–658.
115. 115 Redman, C.W., Sargent, I.L., Latest advances in understanding preeclampsia. Science 308 (2005), 1592–1594.
116. 116 Roberts, J., Pre-eclampsia a two-stage disorder: what is the linkage? Are there directed fetal/placental signals?. Lyall, F., Belfort, M., (eds.) Pre-eclampsia: etiology and clinical practice, 2007, Cambridge University Press, New York, 183–194.
117. 117 Roberts, J.M., Hubel, C.A., The two stage model of preeclampsia: variations on the theme. Placenta 30:Suppl (2009), S32–S37.
118. 118 Venkatesha, S., Toporsian, M., Lam, C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006), 642–649.
119. 119 Levine, R.J., Maynard, S.E., Qian, C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004), 672–683.
120. 120 Chaiworapongsa, T., Romero, R., Espinoza, J., et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 190 (2004), 1541–1550.
121. 121 Chaiworapongsa, T., Romero, R., Kim, Y.M., et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 17 (2005), 3–18.
122. 122 Widmer, M., Villar, J., Benigni, A., et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 109 (2007), 168–180.
123. 123 Romero, R., Nien, J.K., Espinoza, J., et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 21 (2008), 9–23.
124. 124 Erez, O., Romero, R., Espinoza, J., et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 21 (2008), 279–287.
125. 125 Karumanchi, S.A., Stillman, I.E., Lindheimer, M.D., Angiogenesis and preeclampsia. Lindheimer, M.D., Roberts, J.M., Cunningham, F.G., (eds.) Chesley's hypertensive disorders in pregnancy, 3rd ed., 2009, Elsevier, San Diego, 87–104.
126. 126 Espinoza, J., Uckele, J.E., Starr, R.A., et al. Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 203 (2010), 17.e1–17.e8.
127. 127 Chaiworapongsa, T., Romero, R., Savasan, Z.A., et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 24 (2011), 1187–1207.
128. 128 Chaiworapongsa, T., Romero, R., Korzeniewski, S.J., et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol 208 (2013), 287.e1–287.e15.
129. 129 Chaiworapongsa, T., Chaemsaithong, P., Korzeniewski, S.J., et al. Pre-eclampsia part 2: prediction, prevention and management. Nat Rev Nephrol 10 (2014), 531–540.
130. 130 Ness, R.B., Roberts, J.M., Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175 (1996), 1365–1370.
131. 131 Redman, C.W., Sargent, I.L., Placental debris, oxidative stress and pre-eclampsia. Placenta 21 (2000), 597–602.
132. 132 Redman, C.W., Sargent, I.L., Pre-eclampsia, the placenta and the maternal systemic inflammatory response–a review. Placenta 24:Suppl (2003), S21–S27.
133. 133 Redman, C.W., Tannetta, D.S., Dragovic, R.A., et al. Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 33:Suppl (2012), S48–S54.
134. 134 Rajakumar, A., Cerdeira, A.S., Rana, S., et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 59 (2012), 256–264.
135. 135 Karumanchi, S.A., Bdolah, Y., Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question. Endocrinology 145 (2004), 4835–4837.
136. 136 Ross, R., Atherosclerosis–an inflammatory disease. N Engl J Med 340 (1999), 115–126.
137. 137 Ross, R., Atherosclerosis is an inflammatory disease. Am Heart J 138 (1999), S419–S420.
138. 138 Vince, G.S., Starkey, P.M., Austgulen, R., et al. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 102 (1995), 20–25.
139. 139 Conrad, K.P., Miles, T.M., Benyo, D.F., Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40 (1998), 102–111.
140. 140 Yudkin, J.S., Kumari, M., Humphries, S.E., et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000), 209–214.
141. 141 Teran, E., Escudero, C., Moya, W., et al. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet 75 (2001), 243–249.
142. 142 Freeman, D.J., McManus, F., Brown, E.A., et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 44 (2004), 708–714.
143. 143 Sharma, A., Satyam, A., Sharma, J.B., Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 58 (2007), 21–30.
144. 144 Belo, L., Santos-Silva, A., Caslake, M., et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy 22 (2003), 129–141.
145. 145 Braekke, K., Holthe, M.R., Harsem, N.K., et al. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Am J Obstet Gynecol 193 (2005), 227–233.
146. 146 Ustun, Y., Engin-Ustun, Y., Kamaci, M., Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 121 (2005), 154–158.
147. 147 Greer, I.A., Haddad, N.G., Dawes, J., et al. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol 96 (1989), 978–982.
148. 148 Sattar, N., Greer, I.A., Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 325 (2002), 157–160.
149. 149 Hermes, W., Franx, A., van Pampus, M.G., et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am J Obstet Gynecol 208 (2013), 474.e1–474.e8.
150. 150 Ahmed, R., Dunford, J., Mehran, R., et al. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 63 (2014), 1815–1822.
151. 151 Alsnes, I.V., Janszky, I., Forman, M.R., et al. A population-based study of associations between preeclampsia and later cardiovascular risk factors. Am J Obstet Gynecol 211 (2014), 657.e1–657.e7.
152. 152 Reister, F., Frank, H.G., Kingdom, J.C., et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81 (2001), 1143–1152.
153. 153 Labarrere, C.A., Ortiz, M.A., Sosa, M.J., et al. Syncytiotrophoblast intercellular adhesion molecule-1 expression in placental villitis of unknown cause. Am J Obstet Gynecol 193 (2005), 483–488.
154. 154 Labarrere, C.A., Bammerlin, E., Hardin, J.W., et al. Intercellular adhesion molecule-1 expression in massive chronic intervillositis: implications for the invasion of maternal cells into fetal tissues. Placenta 35 (2014), 311–317.
155. 155 Xiao, J., Garcia-Lloret, M., Winkler-Lowen, B., et al. ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. Am J Pathol 150 (1997), 1845–1860.
156. 156 Garcia-Lloret, M.I., Winkler-Lowen, B., Guilbert, L.J., Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-alpha. A model for hematogenous initiation of placental inflammations. J Leukoc Biol 68 (2000), 903–908.
157. 157 Goksu Erol, A.Y., Nazli, M., Elis Yildiz, S., Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae. Endocrine 42 (2012), 125–131.
158. 158 Romero, R., Kusanovic, J.P., Chaiworapongsa, T., Hassan, S.S., Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol 25 (2011), 313–327.
159. 159 Kim, Y.M., Chaemsaithong, P., Romero, R., et al. The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion. J Matern Fetal Neonatal Med 28 (2015), 2001–2009.
160. 160 Romero, R., Kusanovic, J.P., Kim, C.J., Placental bed disorders in the genesis of the great obstetrical syndromes. Pijnenborg, R., Brosens, I., Romero, R., (eds.) Placental bed disorders, 2010, Cambridge University Press, New York, NY, 271–289.
161. 161 Korzeniewski, S.J., Romero, R., Chaiworapongsa, T., et al. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. Am J Obstet Gynecol 214 (2016), 629.e1–629.e17.
162. 162 Kim, Y.M., Chaemsaithong, P., Romero, R., et al. Placental lesions associated with acute atherosis. J Matern Fetal Neonatal Med 28 (2015), 1554–1562.
163. 163 Kam, E.P., Gardner, L., Loke, Y.W., et al. The role of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod 14 (1999), 2131–2138.
164. 164 Erlebacher, A., Why isn't the fetus rejected?. Curr Opin Immunol 13 (2001), 590–593.
165. 165 Szekeres-Bartho, J., Immunological relationship between the mother and the fetus. Int Rev Immunol 21 (2002), 471–495.
166. 166 Trowsdale, J., Betz, A.G., Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 7 (2006), 241–246.
167. 167 Rowe, J.H., Ertelt, J.M., Xin, L., et al. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490 (2012), 102–106.
168. 168 Betz, A.G., Immunology: tolerating pregnancy. Nature 490 (2012), 47–48.
169. 169 Erlebacher, A., Immunology of the maternal-fetal interface. Annu Rev Immunol 31 (2013), 387–411.
170. 170 Sabatier, F., Bretelle, F., D'Ercole, C., et al. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction. Am J Obstet Gynecol 183 (2000), 1558–1563.
171. 171 Ogge, G., Romero, R., Chaiworapongsa, T., et al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med 23 (2010), 476–487.
172. 172 Gervasi, M.T., Chaiworapongsa, T., Naccasha, N., et al. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol 185 (2001), 1124–1129.
173. 173 Gervasi, M.T., Chaiworapongsa, T., Naccasha, N., et al. Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 11 (2002), 171–175.
174. 174 Naccasha, N., Gervasi, M.T., Chaiworapongsa, T., et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 185 (2001), 1118–1123.
175. 175 Khong, T.Y., Mott, C., Immunohistologic demonstration of endothelial disruption in acute atherosis in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 51 (1993), 193–197.
176. 176 Khong, T.Y., Sawyer, I.H., Heryet, A.R., An immunohistologic study of endothelialization of uteroplacental vessels in human pregnancy–evidence that endothelium is focally disrupted by trophoblast in preeclampsia. Am J Obstet Gynecol 167 (1992), 751–756.